Literature DB >> 23024427

Melatonin: an adjunctive treatment for cardiometabolic disease?

Helen J Burgess.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23024427      PMCID： PMC3443755          DOI： 10.5665/sleep.2100

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  18 in total

1.  A prospective study of sleep duration and coronary heart disease in women.

Authors:  Najib T Ayas; David P White; JoAnn E Manson; Meir J Stampfer; Frank E Speizer; Atul Malhotra; Frank B Hu
Journal:  Arch Intern Med       Date:  2003-01-27

2.  Prolonged melatonin administration decreases nocturnal blood pressure in women.

Authors:  Angelo Cagnacci; Marianna Cannoletta; Antonietta Renzi; Francesco Baldassari; Serenella Arangino; Annibale Volpe
Journal:  Am J Hypertens       Date:  2005-12       Impact factor: 2.689

3.  Comparison of melatonin products against USP's nutritional supplements standards and other criteria.

Authors:  H Hahm; J Kujawa; L Augsburger
Journal:  J Am Pharm Assoc (Wash)       Date:  1999 Jan-Feb

4.  Effect of atenolol on nocturnal sleep and temperature in young men: reversal by pharmacological doses of melatonin.

Authors:  C J Van Den Heuvel; K J Reid; D Dawson
Journal:  Physiol Behav       Date:  1997-06

5.  Catecholamines are the key for explaining the biological relevance of insulin-melatonin antagonisms in type 1 and type 2 diabetes.

Authors:  E Peschke; K Hofmann; K Pönicke; D Wedekind; E Mühlbauer
Journal:  J Pineal Res       Date:  2011-09-19       Impact factor: 13.007

6.  Effects of bright light and melatonin on sleep propensity, temperature, and cardiac activity at night.

Authors:  H J Burgess; T Sletten; N Savic; S S Gilbert; D Dawson
Journal:  J Appl Physiol (1985)       Date:  2001-09

Review 7.  Effects of poor and short sleep on glucose metabolism and obesity risk.

Authors:  Karine Spiegel; Esra Tasali; Rachel Leproult; Eve Van Cauter
Journal:  Nat Rev Endocrinol       Date:  2009-05       Impact factor: 43.330

8.  Improvement of sleep quality in elderly people by controlled-release melatonin.

Authors:  D Garfinkel; M Laudon; D Nof; N Zisapel
Journal:  Lancet       Date:  1995-08-26       Impact factor: 79.321

9.  Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion.

Authors:  Valeriya Lyssenko; Cecilia L F Nagorny; Michael R Erdos; Nils Wierup; Anna Jonsson; Peter Spégel; Marco Bugliani; Richa Saxena; Malin Fex; Nicolo Pulizzi; Bo Isomaa; Tiinamaija Tuomi; Peter Nilsson; Johanna Kuusisto; Jaakko Tuomilehto; Michael Boehnke; David Altshuler; Frank Sundler; Johan G Eriksson; Anne U Jackson; Markku Laakso; Piero Marchetti; Richard M Watanabe; Hindrik Mulder; Leif Groop
Journal:  Nat Genet       Date:  2008-12-07       Impact factor: 38.330

10.  Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.

Authors:  Doron Garfinkel; Mariana Zorin; Julio Wainstein; Zipora Matas; Moshe Laudon; Nava Zisapel
Journal:  Diabetes Metab Syndr Obes       Date:  2011-08-02       Impact factor: 3.168
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.